BIBLIOGRAPHY \l 1040 1.
Stummer W et al.,
Fluorescenceguided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.
Lancet Oncol,
2006.
7(5):392-401.
2.
Stupp R et al.,
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med,
2005.
352: 987-996.
3.
Ng WH et al.,
Higher glioblastoma tumour burden reduces efficacy of chemotherapeutic agents: in vitro evidence.
J Clin Neurosci,
2007.
14: 261-266.
4.
Suchorska B et al.,
Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma—results from the DIRECTOR trial. Neuroncology,
2016.
18: 549-556.
5.
Bette S et al.,
Patterns and Time Dependence of Unspecific Enhancement in Postoperative Magnetic Resonance Imaging After Glioblastoma Resection.
World Neurosurg,
2016.
90: 440-447.
6.
Brandes AA et al.,
Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation with MGMT promoter methylation status. J Clin Oncol,
2009.
27(8): 1275-1259.
7.
Lara-Velazquez M et al.,
Advances in Brain Tumor Surgery for Glioblastoma in Adults. Brain Sci,
2017.
7 (12): 1-16.
8.
Forsting M et al.,
Extirpation of Glioblastomas: MR and CT follow-up of residual tumor and regrowth patterns. AJNR,
1993.
14:77-87.
9.
Meyding-Lamade U et al.,
Accelerated methaemoglobin formation: potential pitfall in early postoperative MRI.
Neuroradiology,
1993.
35 (3): 178-180.
10.
Ekinci G et al.,
Early-postoperative magnetic resonance imaging in glial tumors: prediction of tumor regrowth and recurrence. Eur J Radiol,
2003.
45 (2): 99-107.
11.
Albert FK et al., Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence of regrowth and prognosis. Neurosurgery,
1994.
34: 45-61.
12.
Leshcer S et al.,
Time window for postoperative reactive enhancement after resection of brain tumors: less than 72 hours. Neurosurg Focus,
2014.
37 (6): 1-6.
13.
David NL et al.,
The 2016 World Health Organization Classification of Tumors. 2016,
131 (6): 803-820.
14.
Stummer W et al.,
Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery,
2008.
62: 564-576.
15.
Xing Y et al.,
Which Parameter Is More Important for the Prognosis of New-Onset Adult Glioblastoma: Residual Tumor Volume or Extent of Resection? World Neurosurg,
2018.
116: 444-551.
16.
Carles M et al.,
Early post-operative magnetic resonance imaging in glioblastoma: correlation among radiological findings and overall survival in 60 patients. Eur Radiol,
2015.
26: 1048-1055.
17.
Sato N et al.
Postoperative changes in the brain: MR imaging findings in patients without neoplasms. Radiology,
1997.
204: 839-846.
18.
Anzalone N et al.,
Optimizing contrast-enhanced magnetic resonance imaging characterization of brain metastases: relevance to stereotactic radiosurgery. Neurosurgery,
2013.
72 (5): 691-701.
19.
Haustein J et al.,
Administration of gadopentate dimeglutamine in MR imaging of intracranial tumors: dosage and filed strength. AJNR,
1992.
13: 1199-1206.
20.
Hagiwara A et al.,
Contrast-enhanced synthetic MRI for the detection of brain metastases.
Acta Radiol Open, 2016.
5: 1-6.
21.
Ulmer S et al.,
Intraoperative perfusion magnetic resonance imaging: Cutting-edge improvement in neurosurgical procedures. Word J Radiol,
2014.
6: 538-543.
22.
Belhawi SMK et al.,
Early postoperative MRI overestimates residual tumour after resection of gliomas with no or minimal enhancement. Eur Radiol,
2011.
21: 1523-34.